Has Aurora (TSX:ACB) Finally Passed Canopy Growth (TSX:WEED) as the Cannabis Industry Leader?

Canopy Growth (TSX:WEED)(NYSE:CGC) has been the industry leader since day one, but has Aurora Cannabis (TSX:ACB)(NYSE:ACB) finally closed the gap and passed it for top spot?

| More on:

For many cannabis investors, the goal is to own the industry leader, as it is sure to reward you with great profits down the road.

The cannabis industry is one that’s finding its feet slowly, but when it’s established, it has the chance to bring great profits to participating companies, especially to those that lead the industry.

Since day one, Canopy Growth (TSX:WEED)(NYSE:CGC) has been the pinnacle of the industry. It was the first company to hit a number of milestones, including being publicly listed on a securities exchange.

Now though, as Canopy has lagged behind some of its competitors recently, has Aurora Cannabis (TSX:ACB)(NYSE:ACB) finally caught up and passed it as the cannabis industry leader?

Aurora

Aurora has always been one of the top companies in the cannabis industry. It’s been chasing down Canopy for top spot.

While both companies have similar strategies, they each have their respective differences. Aurora has really been pushing its international growth, with sales in 25 different countries, making it the market leader for medical cannabis in Europe and Latin America.

It’s made 17 total acquisitions since 2016, which it has integrated into its existing operations well and used the synergies to improve its growth potential.

Its fourth-quarter fiscal 2019 earnings were very impressive with net revenue up more than 50% over the third quarter and the volume of cannabis sold up almost 100%.

Aurora has worked hard to chase down Canopy, but it now realizes it needs to prioritize profitability, as that’s what investors are interested in.

Its strategy for profitability includes plans to drive down costs and give itself some wiggle room for what it sees as inevitable margin compression in the future.

In addition, it has been investing heavily in R&D to give itself flexibility while building its brand names to try and charge a premium for its products down the road.

The stock has come down by roughly 65% since its peak earlier this year in March, making it a steal at today’s prices.

Canopy

Canopy, as mentioned before, has been the industry leader for a number of reasons, but mostly because it has been the one company to achieve a number of firsts in the industry.

This has given it a major early mover advantage and has positioned it to dominate the recreational, medical, and international markets.

It now has more than 110 patents and operations in 12 countries on five different continents around the world.

It’s also been working hard to develop its retail store network building out its Tweed-branded stores as well as its iconic Tokyo Smoke stores.

These stores are critical to gaining an advantage in the recreational market and are part of the reason why Canopy has an estimated 25% market share in the Canadian recreational market.

On top of all the growth it’s seeing from recreational and international sales, it is also working hard to develop its Cannabis 2.0 products.

The future has never been brighter for Canopy, and with its stock being sold off by more than 60% since the beginning of May, this could be the best time to invest, because it’s extremely undervalued and the perfect contrarian pick.

Bottom line

It’s clear that the cannabis industry has had a huge sell off, but this could be seen as a positive, as most speculators have now exited the industry. This makes it a great time for long-term investors to step in and hold the stocks until they reach their fair-value potential.

While Canopy continues to lead the industry, Aurora has closed the gap, and it will be interesting to see how they fare over the next 12 months. For investors trying to decide one over the other though, I would give the slight edge to Canopy, though you can’t go wrong investing in either company.

Should you invest $1,000 in Brookfield Infrastructure Partners right now?

Before you buy stock in Brookfield Infrastructure Partners, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Brookfield Infrastructure Partners wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »